- Home
- AMLX vs JFIN Comparison
AMLX vs JFIN Comparison
Compare AMLX & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- JFIN
- Stock Information
- Founded
- AMLX 2014
- JFIN 2011
- Country
- AMLX United States
- JFIN China
- Employees
- AMLX N/A
- JFIN N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- JFIN Finance: Consumer Services
- Sector
- AMLX Health Care
- JFIN Finance
- Exchange
- AMLX Nasdaq
- JFIN Nasdaq
- Market Cap
- AMLX 749.9M
- JFIN 682.1M
- IPO Year
- AMLX 2022
- JFIN 2019
- Fundamental
- Price
- AMLX $12.77
- JFIN $11.33
- Analyst Decision
- AMLX Strong Buy
- JFIN
- Analyst Count
- AMLX 7
- JFIN 0
- Target Price
- AMLX $14.86
- JFIN N/A
- AVG Volume (30 Days)
- AMLX 2.0M
- JFIN 135.4K
- Earning Date
- AMLX 11-06-2025
- JFIN 08-20-2025
- Dividend Yield
- AMLX N/A
- JFIN 7.07%
- EPS Growth
- AMLX N/A
- JFIN 33.85
- EPS
- AMLX N/A
- JFIN 4.21
- Revenue
- AMLX N/A
- JFIN $908,895,698.00
- Revenue This Year
- AMLX N/A
- JFIN N/A
- Revenue Next Year
- AMLX N/A
- JFIN N/A
- P/E Ratio
- AMLX N/A
- JFIN $2.59
- Revenue Growth
- AMLX N/A
- JFIN 8.19
- 52 Week Low
- AMLX $2.60
- JFIN $5.18
- 52 Week High
- AMLX $13.07
- JFIN $19.23
- Technical
- Relative Strength Index (RSI)
- AMLX 82.10
- JFIN 37.89
- Support Level
- AMLX $11.42
- JFIN $10.85
- Resistance Level
- AMLX $12.25
- JFIN $11.42
- Average True Range (ATR)
- AMLX 0.59
- JFIN 0.67
- MACD
- AMLX 0.21
- JFIN -0.02
- Stochastic Oscillator
- AMLX 91.70
- JFIN 25.16
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.